IRF7 and neoplasm: This might be attributed to TGF-β and TNF-α as major soluble factors involved in the functional alteration of tumor associated pDCs, via inhibition of IRF-7 expression and nuclear translocation in pDC after their exposure to tumor-derived supernatants or recombinant TGF-β1 and TNF-α [55].